门诊儿童社区获得性肺炎的抗生素选择与临床结局
结果显示大环内酯单药最常用(43.2%),广谱抗生素较窄谱抗生素后续住院风险更高(aOR 1.34),大环内酯单药较低(aOR 0.64),但绝对风险差异均小于0.5%。
要点
- 门诊儿童社区获得性肺炎中大环内酯单药使用最多(43.2%)。
- 广谱抗生素较窄谱抗生素后续住院风险更高(aOR 1.34)。
- 大环内酯单药较窄谱抗生素后续住院风险更低(aOR 0.64)。
核心结论
- 大环内酯类是门诊儿童社区获得性肺炎最常用的抗生素,后续住院和重症肺炎均罕见,未来应减少广谱抗生素和大环内酯类处方。
主要发现
- 大环内酯单药使用占43.2%,窄谱抗生素占26.1%,广谱抗生素占24.7%。
- 1488例(0.59%)后续住院,117例(0.05%)发生重症肺炎。
- 与窄谱抗生素相比,广谱抗生素后续住院风险更高(aOR 1.34;95% CI 1.17-1.52)。
- 大环内酯单药(aOR 0.64;95% CI 0.55-0.73)及大环内酯联合窄谱抗生素(aOR 0.62;95% CI 0.39-0.97)后续住院风险更低。
- 大环内酯单药较窄谱抗生素重症肺炎风险更低(aOR 0.56;95% CI 0.33-0.93),但所有分析的绝对风险差异小于0.5%。
临床怎么用
- 门诊儿童社区获得性肺炎应优先考虑窄谱抗生素,减少广谱抗生素和大环内酯类的不必要使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To describe antibiotic prescribing patterns in ambulatory children with community-acquired pneumonia and to assess the relationship between antibiotic selection and clinical outcomes. STUDY DESIGN: This was a retrospective cohort study of ambulatory Medicaid-enrolled children 0-18 years of age diagnosed with community-acquired pneumonia from 2010 to 2016. The exposure was antibiotic class: narrow-spectrum (aminopenicillins), broad-spectrum (amoxicillin/clavulanate and cephalosporins), macrolide monotherapy, macrolides with narrow-spectrum antibiotics, or macrolides with broad-spectrum antibiotics. The associations between antibiotic selection and the outcomes of subsequent hospitalization and development of severe pneumonia (chest drainage procedure, intensive care admission, mechanical ventilation) were assessed, controlling for measures of illness severity. RESULTS: Among 252 177 outpatient pneumonia visits, macrolide monotherapy was used in 43.2%, narrow-spectrum antibiotics in 26.1%, and broad-spectrum antibiotics in 24.7%. A total of 1488 children (0.59%) were subsequently hospitalized and 117 (0.05%) developed severe pneumonia. Compared with children receiving narrow-spectrum antibiotics, the odds of subsequent hospitalization were higher in children receiving broad-spectrum antibiotics (aOR, 1.34; 95% CI, 1.17-1.52) and lower in children receiving macrolide monotherapy (aOR, 0.64; 95% CI, 0.55-0.73) and macrolides with narrow-spectrum antibiotics (aOR, 0.62; 95% CI, 0.39-0.97). Children receiving macrolide monotherapy had lower odds of developing severe pneumonia than children receiving narrow-spectrum antibiotics (aOR, 0.56; 95% CI, 0.33-0.93). However, the absolute risk difference was <0.5% for all analyses. CONCLUSIONS: Macrolides are the most commonly prescribed antibiotic for ambulatory children with community-acquired pneumonia. Subsequent hospitalization and severe pneumonia are rare. Future efforts should focus on reducing broad-spectrum and macrolide antibiotic prescribing.
引用
- Lipsett SC, Hall M, Ambroggio L, et al. Antibiotic Choice and Clinical Outcomes in Ambulatory Children with Community-Acquired Pneumonia. J Pediatr. 2020. PMID: 33045236. doi:10.1016/j.jpeds.2020.10.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。